ATE231555T1 - Verbesserungen in bezug auf die herstellung von malariaimpstoffen - Google Patents

Verbesserungen in bezug auf die herstellung von malariaimpstoffen

Info

Publication number
ATE231555T1
ATE231555T1 AT93904239T AT93904239T ATE231555T1 AT E231555 T1 ATE231555 T1 AT E231555T1 AT 93904239 T AT93904239 T AT 93904239T AT 93904239 T AT93904239 T AT 93904239T AT E231555 T1 ATE231555 T1 AT E231555T1
Authority
AT
Austria
Prior art keywords
pct
production
vectors
sec
polypeptides
Prior art date
Application number
AT93904239T
Other languages
English (en)
Inventor
Anthony Arthur Holder
Michael John Blackman
Jonathan Andrew Chappel
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE231555T1 publication Critical patent/ATE231555T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93904239T 1992-02-22 1993-02-22 Verbesserungen in bezug auf die herstellung von malariaimpstoffen ATE231555T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203821A GB9203821D0 (en) 1992-02-22 1992-02-22 Improvements in or relating to malaria vaccine
PCT/GB1993/000367 WO1993017107A1 (en) 1992-02-22 1993-02-22 Improvements in or relating to malaria vaccine

Publications (1)

Publication Number Publication Date
ATE231555T1 true ATE231555T1 (de) 2003-02-15

Family

ID=10710868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93904239T ATE231555T1 (de) 1992-02-22 1993-02-22 Verbesserungen in bezug auf die herstellung von malariaimpstoffen

Country Status (13)

Country Link
US (1) US5720959A (de)
EP (1) EP0627004B1 (de)
JP (1) JPH07504321A (de)
KR (1) KR100262624B1 (de)
AT (1) ATE231555T1 (de)
AU (1) AU666519B2 (de)
CA (1) CA2128109C (de)
DE (1) DE69332652T2 (de)
DK (1) DK0627004T3 (de)
ES (1) ES2192556T3 (de)
GB (1) GB9203821D0 (de)
NZ (1) NZ249208A (de)
WO (1) WO1993017107A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
AU762945B2 (en) 1998-08-21 2003-07-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Recombinant multivalent malarial vaccine against plasmodium falciparum
AU1600401A (en) 1999-11-12 2001-06-06 Chinese University Of Hong Kong, The Malaria vaccine
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
US20030104003A1 (en) * 2001-05-25 2003-06-05 James Anthony A. Novel surface protein of the malaria parasite plasmodium falciparum
US20090047303A1 (en) * 2005-05-16 2009-02-19 Alan Shaw Method for improving the immunogenicity of plasmodium antigens
US7931908B2 (en) * 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071705B1 (de) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoen-Antigen

Also Published As

Publication number Publication date
GB9203821D0 (en) 1992-04-08
ES2192556T3 (es) 2003-10-16
AU3570493A (en) 1993-09-13
KR100262624B1 (ko) 2000-08-01
CA2128109A1 (en) 1993-09-02
CA2128109C (en) 2007-09-25
WO1993017107A1 (en) 1993-09-02
AU666519B2 (en) 1996-02-15
JPH07504321A (ja) 1995-05-18
US5720959A (en) 1998-02-24
DE69332652T2 (de) 2003-11-27
DK0627004T3 (da) 2003-05-12
DE69332652D1 (de) 2003-02-27
EP0627004A1 (de) 1994-12-07
KR950700415A (ko) 1995-01-16
EP0627004B1 (de) 2003-01-22
NZ249208A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
IL110284A0 (en) Viral vectors and their use in gene therapy
ATE256191T1 (de) Ein pilz, in dem das area-gen verändert ist, und ein area-gen aus aspergillus oryzae
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
DE69333766D1 (de) Herstellung von phytat-degradierenden enzymen in trichoderma
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
DE69434784D1 (de) Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
EP0681585A4 (de) An tata-bindende proteine assoziierte faktoren, für tafs kodierende nukleinsäuren und verfahren zu ihrer verwendung.
DK0804558T3 (da) Tripeptidylaminopeptidase
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
ATE231555T1 (de) Verbesserungen in bezug auf die herstellung von malariaimpstoffen
AU8258591A (en) Human mk gene and protein sequence
MX9806041A (es) Proteina purificada sr-p70.
EP0605073A3 (de) Molekuläre Klonierung und Expression von Neutral-Protease-Genen.
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
HK1008225A1 (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
NO974713D0 (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
ATE487735T1 (de) Säugetier milchwachstumsfaktor
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
MX9606388A (es) Formas truncadas de la proteina inhibidora kappa b (i kappa b alfa), produccion recombinante de dicha proteina y sus usos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0627004

Country of ref document: EP

REN Ceased due to non-payment of the annual fee